Yaz, Yasmin and Ocella (Generic Yasmin) birth control have made billions of dollars for Bayer and Berlex, who have advertised the oral contraceptives not only for birth control, but also as a cure to acne and premenstrual problems. Tragically, thousands of young women have paid the ultimate price with lethal side effects ranging from blood clots to heart attack, gallbladder injuries and sudden cardiac death.
Tragically, thousands of young women have paid the ultimate price with lethal side effects
Medical experts believe that safety issues relating to blood clots may have surfaced as early as 2001 in the clinical trials for Yasmin. Recent evidence suggests that Berlex, the drug’s original manufacturer, and its successor, Bayer, knew as early as 2003 that users of Yasmin faced twice the risk of suffering blood clots as patients using competing products. Yet, the companies invested millions in advertising, Continue reading
Prior results do not guarantee outcomes.